A double-blind randomised placebo-controlled trial of symptom-triggered alcohol detoxification on a general psychiatric ward

ISRCTN ISRCTN33971222
DOI https://doi.org/10.1186/ISRCTN33971222
Protocol serial number N0151123769
Sponsor Department of Health
Funder North Essex Mental Health Partnership NHS Trust (UK)
Submission date
30/09/2004
Registration date
30/09/2004
Last edited
03/11/2015
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Mental and Behavioural Disorders
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English summary of protocol

Not provided at time of registration

Contact information

Dr Bruce Trathen
Scientific

CDAT
Aylmer House
Kitson Way
The High
Harlow
CM20 1DL
United Kingdom

Study information

Primary study designInterventional
Study designRandomised controlled trial
Secondary study designRandomised controlled trial
Study type Participant information sheet
Scientific titleA double-blind randomised placebo-controlled trial of symptom-triggered alcohol detoxification on a general psychiatric ward
Study objectivesTo test the null hypothesis that there is no significant difference in length of hospital stay between subjects administered symptom-triggered alcohol detoxification and those receiving a detoxification according to usual clinical practice.
Ethics approval(s)Not provided at time of registration
Health condition(s) or problem(s) studiedMental and Behavioural Disorders: Alcohol dependence
InterventionDouble blind randomised control trial of two methods of alcohol detoxification. Randomised to 'symptom-triggered alcohol detoxification' or detoxification according to 'usual clinical practice'.
Intervention typeOther
Primary outcome measure(s)

1. Description of demographics: means, confidence intervals, medians, ranges.
2. Duration of detoxification: means, confidence intervals, t-tests.
3. Rates of completion of detoxification: percentages, chi-square.
4. Intensity of withdrawal symptoms: repeated measures analysis of variance (ANOVA).
5. Overall patient satisfaction: means, t-test.
6. Occurrence of complications of withdrawal: qualitative analysis for physical complications; repeated measures ANOVA for psychiatric symptoms.
7. Total medication used: means, t-tests.
8. Prognostic indicators for various outcomes: ANOVA, analysis of covariance (ANCOVA), linear and logistic regressions.

Key secondary outcome measure(s)

Not provided at time of registration

Completion date30/03/2004

Eligibility

Participant type(s)Patient
Age groupNot Specified
SexNot Specified
Target sample size at registration70
Key inclusion criteria70 patients admitted to one ward and who are identified by staff as requiring alcohol detoxification at the point of admission, and who meet International Statistical Classification of Diseases and Related Health Problems - tenth revision (ICD10) criteria for alcohol dependency.
Key exclusion criteriaDoes not meet inclusion criteria
Date of first enrolment01/04/2003
Date of final enrolment30/03/2004

Locations

Countries of recruitment

  • United Kingdom
  • England

Study participating centre

CDAT
Harlow
CM20 1DL
United Kingdom

Results and Publications

Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Participant information sheet Participant information sheet 11/11/2025 11/11/2025 No Yes

Editorial Notes

03/11/2015: no publications found on PubMed.